IRIS
PINI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.486
EU - Europa 8.181
AS - Asia 3.532
SA - Sud America 602
AF - Africa 67
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 20.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.391
GB - Regno Unito 1.913
RU - Federazione Russa 1.621
CN - Cina 1.419
IT - Italia 1.271
SG - Singapore 1.014
IE - Irlanda 970
SE - Svezia 613
UA - Ucraina 522
BR - Brasile 490
DE - Germania 470
FR - Francia 275
HK - Hong Kong 268
KR - Corea 236
VN - Vietnam 206
FI - Finlandia 188
IN - India 107
ES - Italia 78
BE - Belgio 59
CA - Canada 52
PL - Polonia 52
BD - Bangladesh 49
AR - Argentina 43
NL - Olanda 38
TR - Turchia 34
PK - Pakistan 29
AT - Austria 25
JP - Giappone 25
IR - Iran 24
MX - Messico 24
CZ - Repubblica Ceca 22
ZA - Sudafrica 20
VE - Venezuela 14
AU - Australia 13
CL - Cile 13
EC - Ecuador 13
IQ - Iraq 13
CI - Costa d'Avorio 11
CO - Colombia 11
EU - Europa 11
PH - Filippine 11
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CH - Svizzera 9
IL - Israele 9
JO - Giordania 9
KE - Kenya 9
LT - Lituania 9
PE - Perù 9
RO - Romania 8
EG - Egitto 7
ID - Indonesia 7
KZ - Kazakistan 7
DK - Danimarca 6
DZ - Algeria 6
TW - Taiwan 6
BY - Bielorussia 5
EE - Estonia 5
MA - Marocco 5
PY - Paraguay 5
SA - Arabia Saudita 5
LA - Repubblica Popolare Democratica del Laos 4
AM - Armenia 3
BB - Barbados 3
BG - Bulgaria 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
ET - Etiopia 2
GR - Grecia 2
KG - Kirghizistan 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
TH - Thailandia 2
BN - Brunei Darussalam 1
CM - Camerun 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
Totale 20.885
Salva come PNG Salva come JPEG
Città #
Southend 1.750
Dallas 1.041
Dublin 959
Fairfield 778
Ashburn 639
Singapore 571
Chandler 554
Siena 482
Moscow 461
Jacksonville 425
Woodbridge 400
Santa Clara 399
Beijing 380
Ann Arbor 349
Seattle 326
Wilmington 321
Houston 302
Menlo Park 260
Hong Kong 259
Hefei 248
Cambridge 246
Seoul 233
Princeton 171
Los Angeles 136
Nanjing 133
New York 126
Munich 94
Milan 93
Dong Ket 87
Boardman 84
Florence 72
Helsinki 67
San Mateo 67
The Dalles 63
Málaga 60
Rome 59
Shanghai 57
Nanchang 56
Buffalo 52
San Diego 50
São Paulo 50
Council Bluffs 44
Dearborn 42
Fremont 42
Shenyang 41
Bengaluru 37
Brussels 37
Hebei 34
Turku 34
Ho Chi Minh City 33
London 30
Chicago 29
Redwood City 29
Warsaw 28
Hanoi 25
Brooklyn 24
Kunming 24
Redondo Beach 24
Tianjin 24
Washington 24
Columbus 23
Toronto 23
Bagno a Ripoli 21
Stockholm 21
Changsha 20
Phoenix 20
Brno 19
Nuremberg 19
Düsseldorf 18
Johannesburg 18
Denver 17
Jiaxing 17
San Francisco 17
Tokyo 17
Atlanta 16
Dhaka 16
Montreal 16
Ningbo 16
Vienna 16
Belo Horizonte 15
Chennai 15
Frankfurt am Main 15
Izmir 15
Rio de Janeiro 15
Zhengzhou 15
Gdansk 14
Guangzhou 14
Orem 14
Poplar 14
Hangzhou 13
Kansas City 13
Lappeenranta 13
Amsterdam 12
Jinan 12
Abidjan 11
Brasília 11
Lancaster 11
Arezzo 10
Amman 9
Baku 9
Totale 14.185
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 352
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 342
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 341
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 323
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 307
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 305
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 299
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 290
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 287
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 281
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 281
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 281
A new NT4 peptide-based drug delivery system for cancer treatment 281
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 273
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 272
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 267
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 261
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 260
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 258
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 258
Tumor imaging with tetrabranched neurotensin 254
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 251
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 248
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 247
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 247
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 246
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 245
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 244
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 243
Branched peptides as bioactive molecules for drug design 240
Antibacterial peptides and analogues thereof 234
Branched Neurotensin For Tumor Targeting 234
Branched peptides for tumor diagnosis and therapy 229
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 228
Bioactive peptides from libraries 228
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 228
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 218
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 216
Branched peptides as targeting agents for tumor imaging and therapy 216
D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions 214
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 211
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 210
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 210
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 207
Branched multimeric peptides for tumor diagnosis and therapy 206
Synthetic peptides in the form of dendrimers become resistant to protease activity 206
Esculentin-1a-derived peptides promote clearance of pseudomonas aeruginosa internalized in bronchial cells of cystic fibrosis patients and lung cell migration: Biochemical properties and a plausible mode of action 205
Branched Neurotensin peptides for tumor personalized therapy 204
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 202
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 199
Branched neurotensin for tumor targeting 198
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 198
The development of antimicrobial peptides as new antibacterial drugs 197
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 195
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 195
ANTICORPI E PEPTIDI -I farmaci del XXI secolo- 193
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 193
The antimicrobial peptide M33. An example of drug development 190
Molecular basis of branched peptides resistance to enzyme proteolysis 188
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 187
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 187
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 186
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 184
Tumor selective targeting by branched peptides 181
Neurotensin-derived branched peptides and uses thereof 178
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 169
Phage display and colony filter screening for high-throughput selection of antibody libraries 167
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 167
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 166
Branched peptides as therapeutics 165
Synthetic antidotes against snake neurotoxins 163
COMPOSTI ANTI TNF-ALPHA E LORO USI 162
The antimicrobial peptide M33. An example of drug development 156
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform 152
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 150
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 150
Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa 150
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 149
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 148
Tumor imaging with tetrabranched neurotensin 148
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 147
Branched neurotensin peptides for tumor targeting 147
Strategies for the construction and use of peptide and antibody libraries displayed on phages. 144
Peptide sequences, their branched form and use thereof for antimicrobial applications 143
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 142
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 140
Dendrimeric peptides for tumor targeting 139
Phage display of antibody fragments 135
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 131
Synthetic peptides in the form of dendrimers can become resistant to protease activity 131
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 130
Synthetic inhibitors of anthrax lethal toxin 129
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 128
Antimicrobial Peptides towards Clinical Application-A Long History to Be Concluded 128
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 126
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 125
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 122
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 121
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 117
Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases 116
Totale 20.442
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.736 0 0 0 0 0 330 226 307 205 310 152 206
2021/20221.476 87 157 96 157 93 62 60 78 58 165 171 292
2022/20232.050 114 207 253 279 221 384 50 161 170 85 87 39
2023/20241.572 51 49 130 77 69 440 550 34 8 35 20 109
2024/20253.193 72 140 358 185 390 181 126 200 241 119 331 850
2025/20265.091 565 1.040 846 930 1.470 240 0 0 0 0 0 0
Totale 21.167